Related Experiment Video
Updated: Jun 23, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Breast-feeding reduces the risk for childhood eczema
Inger Kull1, Maria Böhme, Carl-Fredrik Wahlgren
1Department of Occupational and Environmental Health, Stockholm County Council, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. inger.kull@sll.se
Insights
Exclusive breastfeeding for at least four months significantly lowers the risk of childhood eczema and the allergy march by age four. This finding supports the protective benefits of prolonged breastfeeding for infant health.
Area of Science:
- Pediatrics
- Allergy and Immunology
- Public Health
Background:
- The protective effect of breastfeeding against childhood eczema is debated.
- Previous studies have yielded conflicting results on breastfeeding's role in preventing allergic diseases.
Purpose of the Study:
- To examine the impact of breastfeeding on various eczema phenotypes up to four years of age.
- To clarify the relationship between breastfeeding duration and the development of allergic conditions in children.
Main Methods:
- A birth cohort study involving 4089 children.
- Data collected via questionnaires at 2 months, and 1, 2, and 4 years, including breastfeeding, allergic symptoms, and confounders.
- Analysis of blood-specific IgE at age 4, with exclusion of children with concurrent symptoms to prevent exposure modification.
Main Results:
- Exclusive breastfeeding for >= 4 months reduced eczema risk by age 4 (OR, 0.78).
- This protective effect was most pronounced for persistent eczema starting in the first two years (OR, 0.59).
- Breastfeeding also showed a protective effect against the allergy march (OR, 0.48).
Conclusions:
- Breastfeeding for four months or longer is associated with a reduced risk of eczema.
- Prolonged breastfeeding may prevent the onset of the allergy march by age four.
Background:
The evidence for a preventive effect of breast-feeding on the development of eczema in childhood remains controversial.
Objective:
To investigate the effect of breast-feeding in various phenotypes of eczema to 4 years.
Methods:
A birth cohort of 4089 children made up the study base. Data on breast-feeding, allergic symptoms, and potential confounders were obtained from questionnaires when the children were 2 months and 1, 2, and 4 years old. At 4 years, blood specific IgE was analyzed. Children with symptoms of eczema and asthma during the period of breast-feeding were excluded in most analyses on risk assessment of eczema and asthma, respectively, to avoid disease-related modification of exposure.
Results:
Exclusive breast-feeding for >or=4 months reduced the risk for eczema at the age of 4 years (odds ratio [OR], 0.78; 95% CI, 0.63--0.96) irrespective of combination with asthma, sensitization to common allergens, or parental allergic disease. This decreased risk was most evident for children with onset of eczema during the first 2 years persisting to 4 years (OR, 0.59; 95% CI, 0.45--0.77). Among children with early-onset eczema, irrespective of persistency, followed by late onset of asthma or early-onset asthma irrespective of persistency, followed by late-onset eczema to 4 years, a protective effect of breast-feeding was also seen (OR, 0.48; 95% CI, 0.30--0.76).
Conclusion:
Breast-feeding 4 months or more reduces the risk for eczema and onset of the allergy march to age 4.
More Related Videos
08:12Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota
Acne Infection